High frequency of potential phosphodiesterase type 5 inhibitor drug interactions in males with HIV infection and erectile dysfunction
Abstract
We sought to determine the prevalence of phosphodiesterase type 5 inhibitor (PDE-5) mediated drug-drug interactions (DDIs) in males with HIV infection receiving antiretroviral therapy (ART) and identify factors associated with PDE-5-mediated DDIs.
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- May 06, 2021
- Source ID
- 10.1371/journal.pone.0250607
Entities
People
- Anuradha Ganesan
- Brian K. Agan
- Jason F. Okulicz
- Jason M. Blaylock
- Jason M. Cota
- John D. Fields
- Nathan Jansen
- Rhonda E. Colombo
- Ryan Maves
- Taylor M. Benavides
Organizations
- National Institutes of Health
- Uniformed Services University of the Health Sciences